Craft

Oxford Biodynamics

Stock Price

£0

2024-10-29

Market Capitalization

£3.9 M

2024-10-29

Revenue

£1.1 M

FY, 2025

Oxford Biodynamics Summary

Company Summary

Overview
Oxford BioDynamics Plc is a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch™, based on the latest advances in gene expression, non-coding RNA and epigenetics. EpiSwitch™ is a proprietary industrial platform for the discovery, evaluation, validation and monitoring of a novel class of epigenetic biomarkers known as ‘chromosome conformation signatures’. The company's proprietary technology platform enables pharmaceutical companies to accelerate and improve the rate of drug discovery and development.
Type
Public
Status
Active
Founded
2007
HQ
Oxford, GB | view all locations
Website
http://www.oxfordbiodynamics.com/
Cybersecurity rating
Sectors

Key People

  • Matthew Wakefield

    Matthew Wakefield, Non-Executive Chairman

    • Alexandre Akoulitchev

      Alexandre Akoulitchev, Chief Scientific Officer & Director

    • Jon Burrows

      Jon Burrows, Chief Executive Officer & Director

    • Paul Stockdale

      Paul Stockdale, Chief Financial Officer & Director

    LocationsView all

    7 locations detected

    • Oxford, England HQ

      United Kingdom

      The Quorum, 7600 Oxford Business Park

    • New York, NY

      United States

      1095 6th Ave

    • George Town, Penang

      Malaysia

      118, Jln Tanjung Tokong, Seri Tanjung Pinang

    • Halesowen, England

      United Kingdom

      Neville House, Steelpark Rd

    • London, England

      United Kingdom

      65 Gresham St

    • Oxford, England

      United Kingdom

      Beaumont St

    and 1 others

    Oxford Biodynamics Financials

    Summary Financials

    Revenue (FY, 2025)
    £1.1M
    Gross profit (FY, 2025)
    £551.0K
    Net income (FY, 2025)
    (£11.2M)
    Cash (FY, 2025)
    £1.4M
    EBIT (FY, 2025)
    (£11.0M)
    Enterprise value
    $7.6M

    Footer menu